Lundbeck’s potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan

VALBY, Denmark, March 10, 2025 /PRNewswire/ — The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). H. Lundbeck A/S…